Health Condition 1: null- Patients suffering from Chronic Stable Bronchitis and Patients having FEV1 80%.
Conditions
Interventions
Intervention1: Sitopaladi Churna: Sitopaladi Churna 3gm thrice daily with Honey for 84 days
Sponsors
Central Council For Research in Ayurvedic Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of either sex aged between 18 to 65years. 2. Patients suffering from Chronic Stable Bronchitis. (Chronic Bronchitis is defined as a cough that occurs every day with sputum production that lasts for at least three months, two years in a row). 3. Patients having FEV1 > 80%. 4. Patient willing and able to participate in the study for 16 weeks.
Exclusion criteria
Exclusion criteria: 1. Any other pulmonary diagnosis like Emphysema, Cor pulmonale, Cyanosis, Pneumonia, Asthma, Cystic fibrosis, Tuberculosis, Lung cancer etc. 2.Known case of Diabetes Mellitus 3.Patients with poorly controlled Hypertension ( >=160 / 100 mmHg). 4. Patients on prolonged ( > 6 weeks) medication with corticosteroids, bronchodilators, Mast cell stabilizers, antidepressants, anticholinergics, etc. or any other drugs that may have an influence on the outcome of the study. 5. Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho-Neuro-Endocrinal disorders etc). 6. Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months. 7. Symptomatic patients with clinical evidence of Heart failure. 8. Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2 times upper normal limit) or Renal Disorders (defined as S. Creatinine >1.2mg/dL). 9. Smokers/alcoholics and/or drug abusers. 10. Patients who have completed participation in any other clinical trial during the past six (06) months. 11. Any other condition which the Investigator thinks may jeopardize the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the clinical symptoms of Chronic Bronchitis..Timepoint: NA | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of life outcome from St. Georgeâ??s Respiratory Questionnaire (SGRQ) Score. 2. Change in Leicester Cough Questionnaire Scores Timepoint: 3 months | — |
Countries
India
Contacts
Public ContactDr Deepa Makhija
Central Ayurveda Research Institute for cardio vascular diseases
Outcome results
None listed